Integra LifeSciences Holdings Corporation - Laporan Laba Rugi (TTM)

Integra LifeSciences Holdings Corporation
US ˙ NasdaqGS ˙ US4579852082

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Integra LifeSciences Holdings Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,378 1,372 1,378 1,509 1,526 1,542 1,559 1,567 1,565 1,558 1,562 1,545 1,543 1,542 1,530 1,567 1,565 1,611 1,624 1,622
Change (%) -0.47 0.42 9.53 1.10 1.11 1.07 0.50 -0.11 -0.48 0.27 -1.06 -0.18 -0.06 -0.78 2.41 -0.10 2.91 0.86 -0.16
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 493 521 498 539 550 598 568 571 576 587 580 577 586 594 601 627 632 651 670 689
Change (%) 5.72 -4.43 8.31 1.98 8.73 -5.01 0.48 0.99 1.93 -1.34 -0.38 1.49 1.32 1.20 4.38 0.85 3.00 2.84 2.84
% of Revenue 35.74 37.97 36.13 35.73 36.04 38.76 36.42 36.42 36.82 37.71 37.10 37.36 37.98 38.51 39.28 40.03 40.41 40.45 41.24 42.48
Gross Operating Profit 886 851 880 970 976 945 991 996 989 970 982 968 957 948 929 939 933 959 954 933
Change (%) -3.92 3.39 10.22 0.61 -3.19 4.92 0.51 -0.73 -1.88 1.24 -1.46 -1.18 -0.91 -2.01 1.14 -0.74 2.85 -0.49 -2.26
% of Revenue 64.26 62.03 63.87 64.27 63.96 61.24 63.58 63.58 63.18 62.29 62.90 62.64 62.02 61.49 60.72 59.97 59.59 59.55 58.76 57.52
SG&A 573 595 555 597 604 637 614 619 625 616 615 601 595 593 595 619 634 666 670 673
Change (%) 3.72 -6.63 7.63 1.15 5.48 -3.63 0.81 0.95 -1.41 -0.29 -2.15 -1.11 -0.33 0.47 3.93 2.42 5.01 0.66 0.51
% of Revenue 41.58 43.34 40.29 39.59 39.61 41.33 39.40 39.52 39.94 39.57 39.35 38.91 38.55 38.44 38.93 39.50 40.50 41.32 41.24 41.52
R&D 77 77 68 72 74 93 79 82 81 101 84 81 84 83 81 87 91 97 97 94
Change (%) 0.25 -11.79 4.96 3.54 25.44 -15.55 4.82 -1.11 24.23 -16.79 -3.43 3.29 -1.37 -1.67 7.15 4.66 6.66 -0.73 -2.53
% of Revenue 5.60 5.64 4.95 4.75 4.86 6.03 5.04 5.26 5.20 6.50 5.39 5.26 5.44 5.37 5.33 5.57 5.84 6.05 5.95 5.81
OpEx 1,172 1,220 1,146 1,230 1,246 1,342 1,274 1,285 1,294 1,319 1,291 1,273 1,277 1,282 1,290 1,346 1,371 1,429 1,451 1,471
Change (%) 4.13 -6.07 7.26 1.29 7.78 -5.08 0.83 0.75 1.87 -2.08 -1.44 0.37 0.32 0.66 4.35 1.85 4.19 1.60 1.39
% of Revenue 85.04 88.97 83.22 81.49 81.64 87.03 81.74 82.01 82.71 84.66 82.68 82.36 82.81 83.13 84.33 85.93 87.61 88.70 89.35 90.73
Operating Income 206 151 231 279 280 200 285 282 271 239 271 273 265 260 240 220 194 182 173 150
Change (%) -26.61 52.74 20.81 0.26 -28.59 42.37 -0.97 -4.00 -11.73 13.23 0.75 -2.73 -1.91 -7.84 -8.04 -12.04 -6.14 -4.96 -13.11
% of Revenue 14.96 11.03 16.78 18.51 18.36 12.97 18.26 17.99 17.29 15.34 17.32 17.64 17.19 16.87 15.67 14.07 12.39 11.30 10.65 9.27
Interest Expense -68 -72 -67 -64 -56 -50 -49 -48 -49 -50 -50 -50 -51 -51 -53 -59 -65 -71 -76 -78
Change (%) 5.75 -6.74 -3.79 -13.40 -9.40 -2.53 -1.86 1.28 1.58 0.90 0.46 0.50 1.70 2.97 11.70 10.68 8.00 7.35 3.15
% of Revenue -4.91 -5.22 -4.85 -4.26 -3.65 -3.27 -3.15 -3.08 -3.12 -3.18 -3.20 -3.25 -3.28 -3.33 -3.46 -3.77 -4.18 -4.39 -4.67 -4.82
Net Income 56 134 170 206 216 169 157 166 173 181 172 131 101 68 40 24 -7 -7 -29 -501
Change (%) 137.12 27.05 20.83 5.30 -21.88 -7.39 6.21 4.02 4.37 -4.80 -23.62 -23.17 -32.83 -40.61 -41.22 -127.68 6.10 316.99 1,628.92
% of Revenue 4.10 9.76 12.35 13.62 14.19 10.96 10.04 10.61 11.05 11.59 11.00 8.49 6.54 4.39 2.63 1.51 -0.42 -0.43 -1.78 -30.87

Source: Capital IQ

Other Listings
DE:IL3 € 13.30
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista